Meniere's Disease
eBook - PDF

Meniere's Disease

Update 1999

  1. 917 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Meniere's Disease by R. Dauman,E. Ferrary,J.P. Sauvage, R. Dauman, E. Ferrary, J.P. Sauvage in PDF and/or ePUB format, as well as other popular books in Medicine & Ear, Nose & Throat Medicine. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Contents
  2. Preface
  3. History
  4. The history and development of operations on the endolymphatic sac
  5. Vestibular neurotomy as a physiopathological model of vestibular compensation
  6. Bicentenary of P. Menière
  7. Prosper Menière, a precursor aurist
  8. Prosper Menière, from the foreign point of view
  9. Experimental endolymphatic hydrops
  10. An update of our experiences on endolymphatic hydrops
  11. The role of hair cells in Menière’s disease
  12. The role of endolymph flow in homeostasis
  13. Hormonal regulation of the inner ear
  14. Homeostatic mechanisms of the inner ear fluids
  15. The role of Reissner’s membrane in endolymph homeostasis
  16. Ion transport system in epithelial cells of the endolymphatic sac
  17. The endolymphatic sac, an endocrine gland?
  18. K + channels in mouse vestibular dark cells
  19. Characteristics of Na + -H + exchanger of epithelial cells in the endolymphatic sac
  20. Dual effect of glycerol administration on glycoconjugates in the adult guinea pig inner ear
  21. Perilymphatic high potassium in hydrops affects electromotility of outer hair cells
  22. Two-phase endolymphatic hydrops. A new dynamic model for Menière’s disease
  23. Endolymphatic hydrops induced by chronic administration of vasopressin
  24. Effects of antidiuretic hormones in the endolymphatic sac
  25. Electrochemical composition of the luminal fluid and epithelial transports in the guinea pig endolymphatic sac
  26. Aquaporins in the inner ear
  27. Hyperpigmentation in hydropic specimens
  28. Expression of mRNA encoding amiloride-sensitive Na + channel in the endolymphatic sac of the rat
  29. Expression of NO synthase I, II, III, soluble guanylate cyclase and cGMP in experimentally induced endolymphatic hydrops in the guinea pig
  30. New insights into glycerol in experimental endolymphatic hydrops
  31. Hearing preservation after partial labyrinthectomy
  32. Production of endolymphatic hydrops induced by direct infusion of monoclonal antibody against Type II collagen CB11 peptide
  33. Audiovestibular and pressure investigations
  34. Effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière’s disease
  35. Electrocochleography and clinical staging
  36. Caloric testing face-up and face-down in Menière’s disease
  37. Simultaneous measurement of endo- and perilymphatic pressure in the guinea pig during fluid injection
  38. Otoacoustic emissions and Menière’s disease
  39. Pathophysiological mechanisms of Menière’s syndrome based on infrared oculography and histopathology
  40. Vestibular function in Menière patients
  41. Vibration-induced nystagmus in Menière’s disease
  42. Vestibulo-cochlear response to glycerol in Menière’s patients
  43. Effects of glycerol administration to vestibular-evoked myogenic potentials in patients with unilateral Menière’s disease
  44. Effects of proprioceptive disturbance during standing in Menière and other labyrinthine defective subjects
  45. Audiovestibular findings in the course of Menière’s disease
  46. How do we use state-of-the-art vestibular testing to properly diagnose dizzy patients with complaints of disequilibrium?
  47. Low-frequency hearing loss in Menière’s disease
  48. Comparison of pre- and postoperative audiogram patterns in intractable Menière’s disease
  49. Closure of the tympanic membrane after transtympanic electrocochleography
  50. Diagnosis of endolymphatic hydrops by low-frequency modulation
  51. Otoacoustic emissions as acoustic cochleography in diagnosis of Menière’s disease
  52. Electrophysiological investigation of the olivocochlear bundle during vestibular neurotomy
  53. The effect of glycerol on the high-frequency audiometric threshold in hydropic patients
  54. Vestibular-evoked myogenic potentials in patients with unilateral Menière’s disease
  55. Vestibular-evoked myogenic potentials in patients with bilateral Menière’s disease
  56. Vestibular-evoked myogenic potentials in patients with delayed endolymphatic hydrops
  57. Non-invasive perilymphatic pressure measurement in patients with Menière’s disease
  58. Static and dynamic posturography in Menière’s disease
  59. Retrospective investigations in Menière’s disease. The diagnostic value of vestibular recruitment
  60. Clinical investigations
  61. Regional differences in the prevalence of Menière’s disease in Finland
  62. Endolymphatic hydrops and sensorineural hearing loss. A clinico-histological study
  63. The significance of anamnesis in suspected Menière’s disease in young children. Case presentation
  64. Management of Menière’s disease in children
  65. Clinical hints in patients suffering from Menière’s disease
  66. Autonomic nervous system examination in patients with Menière’s disease
  67. Vascular compression of the VIIIth nerve can cause Menière-like hearing loss
  68. Menière’s disease associated with dietary fluid overload. Analysis of 27 cases
  69. Precipitating factors in Menière’s disease
  70. The mechanism which causes the vertigo in Menière’s disease
  71. On the onset of the second ear in patients with bilateral Menière’s disease
  72. Tinnitus and morbus Menière
  73. Menière’s disease and the menstrual cycle
  74. Types of epithelial cell in the human endolymphatic sac
  75. A case of saccular endolymphatic hydrops
  76. The natural history of Menière’s disease. A 28-year progress report
  77. Menière’s disease in the elderly
  78. Introducing a multimedia program for general practitioners and patients with Menière’s disease
  79. Differential diagnosis between Menière’s disease and perilymphatic fistula
  80. Tinnitus in Menière’s disease
  81. Reactive psychogenic dizziness in Menière’s disease
  82. Endolymphatic hydrops. An overview of etiologies
  83. The patient’s perspective
  84. Menière patients’ organizations
  85. β-Tubulin as an autoantigen for autoimmune inner ear disease
  86. Proto-oncogene Raf-1 as an autoantigen in Menière’s disease
  87. Effect of anticochlear antibodies on the evolution of rapidly progressive sensorineural hearing loss and Menière’s disease
  88. Allergy and Menière’s disease
  89. Imaging
  90. Imaging of the fine structure of the inner ear using magnetic resonance microscopy
  91. Three-dimensional magnetic resonance imaging of the inner ear in patients with uni- and bilateral Menière’s disease
  92. Investigation of the saccular function in Menière’s disease patients
  93. Blood flow of the vertebrobasilar artery in vestibular disorders
  94. Medical and in-situ treatments
  95. In situ therapy: from experimental results to clinical applications
  96. Effects of therapeutic middle ear pressure changes in patients with Menière’s disease
  97. Clinical results with the round window microcatheter and microdose gentamicin in the treatment of Menière’s disease
  98. Inner ear localization of medicines delivered via the round window microcatheter
  99. A conservative approach to intratympanic gentamicin therapy. Preliminary results
  100. Self-treatment of inner ear disease using otic medication delivered by the Silverstein MicroWick™
  101. Intratympanic gentamicin instillation as treatment for unilateral Menière’s disease
  102. Transtympanal injections facilitate gentamicin treatment in Menière’s disease
  103. Low-dose streptomycin/dexamethasone perfusion for Menière’s disease
  104. Vestibular function after microcatheter gentamicin compared to transtympanic dosing
  105. Vestibular rehabilitation after low-dose microcatheter gentamicin treatment for Menière’s disease
  106. Intratympanic streptomycin therapy for Menière’s disease. Long-term follow-up
  107. Transtympanic gentamicin in Menière’s disease and impact on quality of life
  108. The prescription of hearing aids in Menière patients
  109. Tinnitus retraining therapy in Menière’s disease
  110. Pressure chamber treatment of Menière’s disease
  111. Oxygen therapy in the immediate and long-term treatment of Menière’s disease
  112. How do we use state-of-the-art techniques to treat the dizzy patient with dysequilibrium?
  113. Betahistine for Menière’s disease. A systematic review
  114. Fast vestibular compensation induced by levosulpiride in acute vertigo attacks
  115. Indications for surgical and non-surgical treatment of vertigo in Menière’s disease
  116. Historical research into a treatment for Menière’s. A pioneer makes the connection (Utermöhlen 1873-1962)
  117. Prism glasses alleviate vertigo in Menière’s disease
  118. Small animal model for assessing vestibular function after gentamicin administration
  119. Intracochlear infusion through the round window membrane. Preliminary results
  120. Intratympanic and systemic dexamethasone treatment of Menière’s disease
  121. Streptomycin perfusion through the round window in patients with Menière’s disease
  122. Surgical treatments
  123. VIIth and VIIIth cranial nerve monitoring in vestibular neurectomy
  124. The long-term outcome of removal of the endolymphatic sac in Menière’s disease
  125. The retrolabyrinthine approach in vestibular neurotomy
  126. Vestibular neurotomy by the retrosigmoid approach
  127. Long-term hearing results after retrosigmoid vestibular neurotomy
  128. Outcomes research after posterior fossa vestibular neurectomy. A 20-year experience
  129. The touchstone in medical versus surgical treatment of Menière’s disease
  130. Sac expanding surgery for Menière’s disease
  131. Length of external opening of vestibular aqueduct and results of endolymphatic shunt for Menière’s disease
  132. Surgical management of Menière’s disease
  133. Endolymphatic sac surgery assisted by videoendoscopy
  134. Auditory findings after vestibular neurectomy for Menière’s disease
  135. Electrocochleographic findings after vestibular neurectomy for Menière’s disease
  136. Retrosigmoid vestibular neurotomy: functional results. Clinical evaluation with otoneurological, physical medicine and orthoptic approaches
  137. Results of vestibular neurotomy by the retrosigmoid approach
  138. Long-term evolution of subjective visual vertical tilt after vestibular neurectomy and labyrinthectomy
  139. Evolution of vestibular symptoms after microvascular decompression
  140. Sac shunt and ultrasound surgery versus gentamicin treatment in Menière’s disease
  141. Stapes surgery, coexisting Menière’s disease and anomalous middle ear. Case report
  142. Results of saccotomy in the treatment of Menière’s disease
  143. Index of authors